1. Weight Regain and Breast Cancer-Related Biomarkers Following an Exercise Intervention in Postmenopausal Women
- Author
-
Christine M. Friedenreich, Kerry S. Courneya, Jessica McNeil, David Valadés, Paola Gonzalo-Encabo, and Alberto Pérez-López
- Subjects
0301 basic medicine ,Epidemiology ,Estrone ,Physiology ,Breast Neoplasms ,Weight Gain ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Sex hormone-binding globulin ,Insulin resistance ,Breast cancer ,Weight loss ,Sex Hormone-Binding Globulin ,Weight Loss ,medicine ,Biomarkers, Tumor ,Humans ,Aged ,biology ,Estradiol ,business.industry ,Weight Fluctuation ,Middle Aged ,medicine.disease ,Confidence interval ,Exercise Therapy ,Postmenopause ,030104 developmental biology ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,biology.protein ,Homeostatic model assessment ,Body Composition ,Female ,medicine.symptom ,business ,Follow-Up Studies - Abstract
Background: Epidemiologic studies have reported associations between weight fluctuations and postmenopausal breast cancer risk; however, the biological markers involved in this association are unknown. This study aimed to explore the associations between breast cancer–related biomarkers and weight regain following exercise-induced weight loss. Methods: From the 400 participants included in the Breast Cancer and Exercise Trial in Alberta, a total of 214 lost weight during the intervention and had follow-up blood samples, body composition, and covariate measurements. Outcomes were measured at baseline, 12 months (end of the study), and 24 months (follow-up). Results: During follow-up, weight regain was 1.80 kg [95% confidence interval (CI): –0.40–3.90], and was significantly associated with increases in estradiol [treatment effect ratio (TER) = 1.03; 95% CI, 1.01–1.04], estrone (TER = 1.02; 95% CI, 1.01–1.03), free estradiol (TER = 1.04; 95% CI, 1.02–1.05), the homeostatic model assessment for insulin resistance (TER = 1.03; 95% CI, 1.02–1.05), and insulin (TER = 1.03; 95% CI, 1.01–1.04), and decreases in sex hormone–binding globulin (SHBG; TER = 0.98; 95% CI, 0.97–0.99) levels. Nonstatistically significant associations were found for glucose and C-reactive protein. Furthermore, a statistically significant linear trend of increasing levels for all biomarkers, and decreasing SHBG, across weight regain categories was found. Conclusions: These results suggest that weight regain following exercise-induced weight loss is associated with breast cancer–related biomarker changes in postmenopausal women. Impact: These findings provide evidence to support the importance of developing effective strategies to prevent weight regain and, consequently, decrease postmenopausal breast cancer risk via changes in adiposity-related biomarkers.
- Published
- 2020